Similarly, ovarian cancer cells demonstrated decreased metastatic potential, with irisin inhibiting PI3K/Akt signalling and downregulating metalloproteinase (MMP)2 and MMP9 [26,48]. This evidence concerns the gene FNDC5 and ovarian cancer.